Automate Your Wheel Strategy on CAH
With Tiblio's Option Bot, you can configure your own wheel strategy including CAH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CAH
- Rev/Share 931.2887
- Book/Share -11.0209
- PB -13.1772
- Debt/Equity -3.0662
- CurrentRatio 0.9351
- ROIC 0.115
- MktCap 36614284020.0
- FreeCF/Share 7.7406
- PFCF 19.7915
- PE 23.4759
- Debt/Assets 0.1605
- DivYield 0.0132
- ROE -0.5205
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 2
- DCF Score 5
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | CAH | Wells Fargo | Equal Weight | Overweight | -- | $179 | June 3, 2025 |
| Upgrade | CAH | Jefferies | Hold | Buy | $140 | $150 | Feb. 5, 2025 |
| Upgrade | CAH | TD Cowen | Hold | Buy | $130 | $144 | Jan. 8, 2025 |
| Upgrade | CAH | Evercore ISI | In-line | Outperform | -- | $140 | Jan. 7, 2025 |
| Upgrade | CAH | BofA Securities | Neutral | Buy | $132 | $145 | Jan. 6, 2025 |
| Upgrade | CAH | Wells Fargo | Underweight | Equal Weight | $101 | $127 | Dec. 13, 2024 |
| Resumed | CAH | Mizuho | -- | Outperform | -- | $139 | Dec. 4, 2024 |
News
Cardinal Health, Inc. (CAH) Presents At Baird Global Healthcare Conference 2025 Transcript
Published: September 10, 2025 by: Seeking Alpha
Sentiment: Neutral
Cardinal Health, Inc. (NYSE:CAH ) Baird Global Healthcare Conference 2025 September 10, 2025 8:30 AM EDT Company Participants Matt Sims - Vice President of Investor Relations Jason Hollar - CEO & Director Aaron Alt - Chief Financial Officer Conference Call Participants Eric Coldwell - Robert W. Baird & Co. Incorporated, Research Division Presentation Eric Coldwell Senior Research Analyst Good to go.
Read More
Is Cardinal Health (CAH) Stock Outpacing Its Medical Peers This Year?
Published: September 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Here is how Cardinal Health (CAH) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year.
Read More
Cardinal Health Expands At-Home Solutions With New Texas Facility
Published: September 08, 2025 by: Zacks Investment Research
Sentiment: Positive
CAH announces the opening of a new distribution center in Texas, which is likely to support its at-Home Solutions business.
Read More
Cardinal Health, Inc. (CAH) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
Published: September 04, 2025 by: Seeking Alpha
Sentiment: Neutral
Cardinal Health, Inc. (NYSE:CAH ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 11:00 AM EDT Company Participants Matt Sims - Vice President of Investor Relations Jason Hollar - CEO & Director Conference Call Participants Stephen Baxter - Wells Fargo Securities, LLC, Research Division Presentation Stephen Baxter Senior Equity Analyst Well, good morning. Steve Baxter, the health care services analyst here at Wells Fargo.
Read More
Cardinal Health at-Home Solutions opens Texas distribution center; announces plans for new California site
Published: September 04, 2025 by: PRNewsWire
Sentiment: Neutral
DUBLIN, Ohio , Sept. 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced the opening of its newest distribution center in Fort Worth, Texas – a facility solely dedicated to the at-Home Solutions business, a leading medical supplies provider that serves more than 6 million people annually in the United States.
Read More
Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"
Published: September 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) could produce exceptional returns because of its solid growth attributes.
Read More
Should Value Investors Buy Cardinal Health (CAH) Stock?
Published: September 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Published: August 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Best Dividend Aristocrats For September 2025
Published: August 27, 2025 by: Seeking Alpha
Sentiment: Positive
Dividend Aristocrats have shown mixed 2025 performance, with some delivering double-digit gains and others lagging, but overall stability remains a hallmark. Dividend growth is robust, with 53 of 69 Aristocrats raising payouts in 2025 and an average growth rate of 5.14%, signaling continued income reliability. My 'Promising Aristocrats' list, focused on undervaluation and projected total return, has outperformed both NOBL and SPY in August.
Read More
5 Dividend Growth Stocks to Boost Your Portfolio
Published: August 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Five dividend growth stocks, AGCO, VRT, TEL, CAH and WWD, stand out for their steady payouts, strong fundamentals and long-term upside potential.
Read More
Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
Read More
All You Need to Know About Cardinal (CAH) Rating Upgrade to Buy
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Should Value Investors Buy Cardinal Health (CAH) Stock?
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Cardinal Health Board of Directors Approves Quarterly Dividend
Published: August 15, 2025 by: PRNewsWire
Sentiment: Neutral
DUBLIN, Ohio , Aug. 15, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on October 15, 2025 to shareholders of record at the close of business on October 1, 2025.
Read More
Cardinal Health to Acquire Solaris Health for Urology Expansion
Published: August 15, 2025 by: Zacks Investment Research
Sentiment: Positive
CAH is set to buy Solaris Health for $2.4B, boosting urology presence with 750+ providers and expanding Specialty Alliance reach.
Read More
After Plunging 9.1% in 4 Weeks, Here's Why the Trend Might Reverse for Cardinal (CAH)
Published: August 13, 2025 by: Zacks Investment Research
Sentiment: Negative
The heavy selling pressure might have exhausted for Cardinal (CAH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Read More
Brokers Suggest Investing in Cardinal (CAH): Read This Before Placing a Bet
Published: August 13, 2025 by: Zacks Investment Research
Sentiment: Negative
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
Cardinal Health to Extend Reach by Acquiring Solaris Health
Published: August 12, 2025 by: PYMNTS
Sentiment: Positive
Cardinal Health's multi-specialty management services organization (MSO), The Specialty Alliance, plans to acquire urology MSO Solaris Health. Cardinal Health will enable the acquisition by providing about $1.9 billion in cash to The Specialty Alliance and will own about 75% of The Specialty Alliance after the acquisition of Solaris Health, Cardinal Health said in a Tuesday (Aug.
Read More
Top Stock Movers Now: Hanesbrands, On Holding, Cardinal Health, and More
Published: August 12, 2025 by: Investopedia
Sentiment: Positive
U.S. equities gained at midday after the latest report on consumer inflation came in lower than expected, boosting hopes of a Federal Reserve rate cut. The Nasdaq and S&P 500 traded at record highs, and the Dow Jones Industrial Average was up as well.
Read More
CAH Q4 Earnings Beat Estimates, '26 EPS View Up, Stock Falls
Published: August 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal Health's fourth-quarter fiscal 2025 results benefit from solid Medical and Other segments' revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.
Read More
Cardinal Health, Inc. (CAH) Q4 2025 Earnings Call Transcript
Published: August 12, 2025 by: Seeking Alpha
Sentiment: Neutral
Cardinal Health, Inc. (NYSE:CAH ) Q4 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Aaron E. Alt - Chief Financial Officer Jason M.
Read More
4 Dental Supplies Stocks Likely to Gain Amid Rising Tariff Risks
Published: August 11, 2025 by: Zacks Investment Research
Sentiment: Negative
Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and COO.
Read More
Can Sustained Product Demand Drive CAH Stock Before Q4 Earnings?
Published: August 08, 2025 by: Zacks Investment Research
Sentiment: Neutral
The continued solid uptake of Cardinal Health's products is expected to have driven fiscal fourth-quarter revenues despite an uncertain macroeconomic environment.
Read More
What Analyst Projections for Key Metrics Reveal About Cardinal (CAH) Q4 Earnings
Published: August 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Beyond analysts' top-and-bottom-line estimates for Cardinal (CAH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Read More
Should Value Investors Buy Cardinal Health (CAH) Stock?
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Cardinal Health Foundation expands Equity Rx to increase access to prescription medications, bringing total investment to $5M
Published: July 30, 2025 by: PRNewsWire
Sentiment: Neutral
Grant funds will also launch the development of Ohio's first statewide prescription drug repository DUBLIN, Ohio , July 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today the expansion of Equity Rx, to help meet the needs of people across Ohio and beyond who cannot afford their prescription medications. Launched as a pilot in Ohio in 2023, Equity Rx was created through a partnership of the Cardinal Health Foundation, the Charitable Healthcare Network (CHN) (an Ohio charitable healthcare organization) and St. Vincent de Paul Charitable Pharmacy in Cincinnati, Ohio.
Read More
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Published: July 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: July 25, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Read More
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Negative
Here is how Cardinal Health (CAH) and Biotricity Inc. (BTCY) have performed compared to their sector so far this year.
Read More
Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?
Published: July 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
About Cardinal Health, Inc. (CAH)
- IPO Date 1983-08-04
- Website https://www.cardinalhealth.com
- Industry Medical - Distribution
- CEO Jason M. Hollar
- Employees 47922